Serum dopamine-beta-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol

Psychopharmacology (Berl). 1976 Nov 24;50(3):259-67. doi: 10.1007/BF00426842.

Abstract

Serum dopamine-beta-hydroxylase activity was estimated in groups of normals and of psychiatric patients, using a thin layer radiochromatographic method. The percentage of patients with schizophrenic and with depressive symptomatology was higher in the population with high enzyme activities. In addition, d-amphetamine given to normals caused an increase in the serum activity while haloperidol caused the opposite effect. The activity in serum is interpreted as a loss in the enzyme from the place it acts physiologically, with possible influence on the noradrenaline synthesis rate.

MeSH terms

  • Depression / enzymology
  • Dextroamphetamine / pharmacology*
  • Dopamine beta-Hydroxylase / blood*
  • Haloperidol / pharmacology*
  • Humans
  • Mental Disorders / enzymology*
  • Schizophrenia / enzymology

Substances

  • Dopamine beta-Hydroxylase
  • Haloperidol
  • Dextroamphetamine